Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023


#774521

100pages

DelveInsight

$ 4950

In Stock

 


Note*: This report requires 7-10 business days to complete.
DelveInsights Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bladder cancer forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Bladder cancer till 2023.


Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Bladder cancer market.
Identifying patient populations in the global Bladder cancermarket to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Bladder cancer therapeutics in each of the markets covered.
To understand the future market competition in the global Bladder cancer therapeutics market and Insightful review of the key market drivers and barriers.


Scope

Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Bladder cancer for United States, EU5 and Japan from 2013 and forecasted Market to 2023.


 

 

Table of Contents

Bladder cancer overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Bladder cancer Market
Global Epidemiology of Bladder cancer Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight




List of Tables


Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Bladder cancer Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Bladder cancer (2013-2023)
Table 7: Bladder cancer Global Market (USD Millions), (2013-2015)
Table 8: Bladder cancer Global Market (USD Millions), (2016-2023)
Table 9: Bladder cancer US Market (USD Millions), (2013-2015)
Table 10: Bladder cancer US Market (USD Millions), (2016-2023)
Table 11: Bladder cancer Germany Market (USD Millions), (2013-2015)
Table 12: Bladder cancer Germany Market (USD Millions), (2016-2023)
Table 13: Bladder cancer United Kingdom Market (USD Millions), (2013-2015)
Table 14: Bladder cancer United Kingdom Market (USD Millions), (2016-2023)
Table 15: Bladder cancer France Market (USD Millions), (2013-2015)
Table 16: Bladder cancer France Market (USD Millions), (2016-2023)
Table 17: Bladder cancer Italy Market (USD Millions), (2013-2015)
Table 18: Bladder cancer Italy Market (USD Millions), (2016-2023)
Table 19: Bladder cancer Spain Market (USD Millions), (2013-2015)
Table 20: Bladder cancer Spain Market (USD Millions), (2016-2023)
Table 21: Bladder cancer Japan Market (USD Millions), (2013-2015)
Table 22: Bladder cancer Japan Market (USD Millions), (2016-2023)
Table 23: Bladder cancer ROW Market (USD Millions), (2013-2015)
Table 24: Bladder cancer ROW Market (USD Millions), (2016-2023)


List of Figures


Figure 1: Bladder cancer Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Bladder cancer (2013-2023)
Figure 3: Bladder cancer Global Market (USD Millions), (2013-2015)
Figure 4: Bladder cancer Global Market (USD Millions), (2016-2023)
Figure 5: Bladder cancer US Market (USD Millions), (2013-2015)
Figure 6: Bladder cancer US Market (USD Millions), (2016-2023)
Figure 7: Bladder cancer Germany Market (USD Millions), (2013-2015)
Figure 8: Bladder cancer Germany Market (USD Millions), (2016-2023)
Figure 9: Bladder cancer United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Bladder cancer United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Bladder cancer France Market (USD Millions), (2013-2015)
Figure 12: Bladder cancer France Market (USD Millions), (2016-2023)
Figure 13: Bladder cancer Italy Market (USD Millions), (2013-2015)
Figure 14: Bladder cancer Italy Market (USD Millions), (2016-2023)
Figure 15: Bladder cancer Spain Market (USD Millions), (2013-2015)
Figure 16: Bladder cancer Spain Market (USD Millions), (2016-2023)
Figure 17: Bladder cancer Japan Market (USD Millions), (2013-2015)
Figure 18: Bladder cancer Japan Market (USD Millions), (2015-2023)
Figure 19: Bladder cancer ROW Market (USD Millions), (2013-2015)
Figure 20: Bladder cancer ROW Market (USD Millions), (2016-2023)


 

NA

NA